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Who Are ‘Informal Health Providers’ and What Do They Do?
Perspectives from Medical Anthropology
Jamie Cross and Hayley MacGregor
Summary
This paper explores gaps and limitations in the conceptualisation, methodology
and policy implications of debates about informal health care providers by 
examining a cross section of empirical studies. Drawing on a tradition of critical
medical anthropology, we argue that existing debates hinge on a particular 
understanding of what constitutes appropriate knowledge and on particular 
expectations of how economic actors in the medical marketplace will behave.
Keywords: informal providers; markets; medicine vendors; access; quality;
expertise.
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1 Introduction: thinking through a
problem
Who are the unlicensed, unregulated or informal private providers of medicinal
services and products in Africa and Asia, and what do they do? Informal providers
of health care vary considerably in terms of: (1) knowledge (formal qualifications
and institutionalised training); (2) the position they occupy in the marketplace
(their commercial orientation or dependence on medicine as a livelihood option);
(3) the complexity or scale of their organisation; and (4) their position in a broader
supply chain of public health commodities (Conteh and Hanson 2003). In a 
growing and heterogeneous literature on the subject there is debate over whether
or not a definition should include traditional healers, or peer educators and lay
health workers whose very roles have been created by development interventions.
Efforts to formulate a bounded definition of informal providers also have a specific
discursive function. They are frequently intended to delineate or make visible a
‘target category’ amenable to technical interventions by development actors and
agencies, with observable public health outcomes. This paper explores gaps and
limitations in the conceptualisation, methodology and policy implications of this
debate by examining a cross section of published research papers on informal
providers.
The question of what to do about the very real problems of dangerous health care
practices among formal and informal private providers is an immediate and 
pressing concern among policymakers, academic researchers as well as civil
society stakeholders (Berman 1998; Mills et al. 2002; Travis and Cassels 2006).
In many low- and middle-income countries, upward of three-fourths of care is 
provided in the non-state sector (WHO/USAID 2007) and the health objectives
established by the Millennium Development Goals add some urgency to engaging
with both formal and informal providers (ICDDR, B 2007). The growing body of
policy oriented literature on the subject is grouped around a set of specific health
priorities, the specific dangers to public health that are presented by the 
diagnostic and dispensing practices of informal providers, and a range of 
proposed interventions. To date most research has focused on issues around
malaria (Goodman et al. 2007; Williams and Jones 2004), tuberculosis (Floyd et
al. 2006; Gharat et al. 2007; Salim et al. 2006) and HIV/AIDS (Brugha 2003; Mills
et al. 2002); as well as to a lesser extent sexual, reproductive and mental health.
Unchecked dispensing practices, meanwhile, have a number of potentially harmful
effects including unintended side effects from super or sub-therapeutic dosages or
from drugs used in combination, increased microbial resistance, for example to
ineffective malaria prophylactics (WHO 2001), and the transmission of blood-
borne diseases like Hepatitis by unsterile administration practices (El Katsha et al.
2006). Studies of the role played by Nigeria’s patent medical vendors in the 
treatment of malaria (Brieger et al. 2004; Okeke et al. 2006; Oladepo et al. 2007),
for example, have focused attention on the sale of cheaper, in-effective, out of
date and poor quality anti-malarials by patent medical vendors and their limited
knowledge of more efficacious artemisinin-based combination drugs. The failure of
informal providers to provide appropriate diagnoses can also result in haphazard
referral systems and delayed decisions in seeking care. In India and Bangladesh,
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for example, the inability of informal providers to recognise the gravity of 
symptoms is seen to contribute to the persistence of high pregnancy related 
morbidity, child and maternal mortality (Killewo, Anwar et al. 2006; George 2007). 
A range of interventions currently seek to bring about explicit improvements in the
quality of care offered by informal providers, harnessing their unmet potential as
public health workers. These are broadly focused around: (1) Knowledge: 
improving the appropriateness of the drugs or information informal providers 
dispense; (2) Performance and safety: increasing access to their goods and 
services, bettering the safety and affordability of their practices; and 
(3) Accountability: building social mechanisms that can regulate their activities
(Travis and Cassels 2006). Knowledge based interventions, that aim to educate or
train both providers and client communities in order to balance asymmetries in 
information, have emerged as one popular model. Market based interventions
which seek to improve the practices of informal providers by introducing good
practice and performance targets, are another. Social franchising and ‘drugs for
performance’ schemes, for example, essentially reward sellers if they comply with
minimum standards of diagnostic procedure, disease classification, treatment 
regimens, referral, recording and reporting procedures.
We argue that such a framing of this contemporary problematic rests on what we
take to be two sets of assumptions. The first set of assumptions hinges on a 
particular understanding of expertise. Ideas about what constitutes appropriate
knowledge proceed from a biomedical frame which calls into question ways of
knowing or practising medicine that fall outside. This is most apparent in the
repeated exclusion of non-allopathic health care providers or alternative, non-
biomedical systems and by the emphasis on universal standards of practice. From
this perspective, informal providers only show up on the health policy radar when
they raise concerns over claims to biomedical expertise or over their use of 
biomedical products. The second set of assumptions hinges on expectations of
how economic actors in the medical marketplace will behave, and are based on a
particular rendering of the human subject as a rational, calculating, profit 
maximising individual. This is most evident in anxieties around the immorality and
self-interest of ‘self made medical authorities’ or ‘entrepreneurial practitioners’. 
This paper seeks to challenge these assumptions by bringing together empirical
studies of informal providers from development academia, public health research,
health economics and medical anthropology. Much of this literature is based on
data collected through questionnaires and some combination of structured 
interviews, observations, simulated client methods (which use actors, role plays
and vignettes), outlet mapping, exit interviews and household surveys (cf.
Goodman et al. 2007). In addition, we sought to include a body of qualitative
anthropological research that too often remains outside the applied arena. While
we acknowledge that ethnographic evidence is not necessarily neutral or 
unproblematic, we looked to draw upon the insights of longitudinal studies that
included observational or ethnographic research tools as part of their 
methodology.  
This paper is not however intended to be a systematic literature review. Rather it
is meant as a discussion paper based upon published research that seeks to flag
a series of issues around knowledge and expertise, markets and economic 
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transactions that are less frequently discussed. Our aim here is not to promote a
new set of interventions but to encourage a critical reflection on the underlying
assumptions, the classificatory schemas, and the kinds of evidence being used to
design regulatory interventions in the medical marketplace. 
Our discussion begins by addressing the global, national and local politics of 
biomedical knowledge. We argue that current debates about informal providers
tend towards the imposition of a classificatory order on the frontlines of the 
medical marketplace. While policymakers are primarily concerned with the 
question of how to effectively and safely practise biomedicine, ‘critical medical
anthropology’ offers an alternative perspective situated outside this frame. 
Our discussion proceeds by exploring research on the transactions that take place
between informal providers and their customers in the medical marketplace. We
argue that portraits of informal providers which draw on only one kind of evidence
tend to establish clear cut distinctions between different kinds of practitioner; 
‘dis-embed’ biomedical transactions from the social structures within which they
take place; invest the motivations and interests of actors with an over-riding 
economic rationality; freeze or anatomise what are dynamic economic 
relationships between stakeholders, and obscure or ignore the position of informal
providers in a global pharmaceutical supply chain. We conclude by asking what
the implications of this critical commentary are for health policy interventions,
focusing on the relational aspect of transactions between informal providers and
their clients and the corporate practices that shape markets in pharmaceutical
commodities (cf. Ecks 2008b).
2 Knowledge economies, expertise 
and legitimacy
New theoretical approaches within health research have begun to address health
care systems as knowledge economies rather than ‘simple assemblages of 
technical services, goods and personnel’ (Bloom and Standing 2008; Bloom et al.
2008; Leonard 2002). This approach reorients health policy interventions aimed at
improving the private sector provision of medicine and places the emphasis on
redressing asymmetries in information. Informational inputs into this knowledge
economy (that aim to improve the knowledge of practitioners about appropriate
medications and drug dosages, and the knowledge of consumers around quality
and performance) are presented as correctives that will assist in the development
of proper functioning markets for curative services and preventative public health. 
For the purposes of this paper we step outside an interventionist health policy
frame to ask what insights can be gained from unpicking the production of 
knowledge in current debates about informal providers. Working within the 
framework of critical medical anthropology we approach biomedical knowledge as
‘discourse’, in that it defines and produces the objects of our knowledge (Hall
1997: 44). Critical medical anthropology emerged from a tradition of Marxist 
political economy to ask how biomedicine is embedded in the capitalist world 
system (Baer et al. 1986). In the Foucauldian tradition, medical anthropologists
IDS WORKING PAPER 334
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ask how biomedical knowledge comes to have authority and how this knowledge
shapes the world that it describes (see Martin 1994; Young 1995). From these
perspectives biomedicine appears as a ‘system amongst systems’, a particularly
modern discipline that readily exerts a hegemonic influence over bodily knowledge
and practice (Lock and Scheper-Hughes 1996). 
We see no contradiction in both advocating biomedical solutions and recognising
that biomedicine is an important field for the production and reproduction of
power. The use of an exclusively biomedical framework to assess the quality of
care offered by informal providers and their level of expertise, however, has 
specific discursive outcomes that shape human subjects and social relations. As
Susan Reynolds Whyte and Harriet Birungi (2000: 172) have written, this is an
intellectual position that raises ‘uneasy questions about the distribution and 
politics of knowledge for those who respect the potential of biomedicine to
improve health’. Who has the right to know what about medicine? And based on
whose rationality? What constitutes appropriate or legitimate knowledge? And
when or under what circumstances do people acquire legitimacy? 
From this starting point, the classifications of biomedical knowledge, practices and
practitioners into discrete categories appear as expressions of interest, authority
and power rather than benign or neutral acts. In this paper, we resist the impulse
to offer a set of definitions that fix who informal providers are and what they do.
By doing so we seek to draw attention to the movement of practitioners between
positions of legitimacy and illegitimacy and the redrawing of boundaries between
what is legitimate and illegitimate as a result of shifts in public health policy.
Taking our cue from Sarah Pinto (Pinto 2004), we understand informal health
providers as people who ‘operate on the boundaries of legitimacy’; people who
are defined by and in relation to legitimating institutions.
2.1 Boundary making
Future health systems, it is said, are ‘unlikely to be characterised by the kinds of
clear boundaries between experts and non experts that have characterised 
twentieth century systems in advanced market economies’ (Bloom and Standing
2008: 8). Yet current debates over informal providers – the type, quantity and
quality of their biomedical knowledge, their qualifications to know or practise 
biomedicine, and the exclusion of those who practise in other traditions (and in
fact frequently integrate elements of biomedicine) – seem precisely to be about
constructing and maintaining boundaries between lay-practitioner and legitimate
expert. Typologies of the medical marketplace that slip into a distinction between
‘doctors and non-doctors’ (Ahmed and Hossain 2007), for example, reveal 
precisely this kind of boundary making. 
If one consequence of the ‘marketisation’ of and spread of health related 
knowledge is a shift in the boundaries of professional expertise (Standing et al.
2008: 4), perhaps we should also expect that national debates over future health
systems will reveal local anxieties among those who have an interest in protecting
and defending their claims to expertise. The construction of boundary lines
between proper or pure biomedical knowledge is socially and historically situated.
In particular contexts and at particular junctures the line between expert and 
inexpert knowledge, appropriate or inappropriate practice, shifts. Community
health workers, for example, represent a classic example of this phenomenon. In
one era they are a solution, in another they become a problem.
Efforts to define legitimate and illegitimate health care providers can often appear
to have a ‘hidden transcript’. At one level concerns over the level of training and
the type of qualifications held by informal providers are about guarantees of 
competence that practitioners can use biomedical knowledge safely. At another
level, however, these concerns can have unintended discursive outcomes that
assert, protect and defend the legitimacy of biomedical experts. Discussions about
private health provision at the national level are thus not necessarily divorced from
the local politics of boundary making that works to maintain authoritative bases of
biomedical expertise.
In South Asia, for example, national debates over concerns about unregulated
informal providers all too easily can reproduce associations between specific ways
of knowing and particular categories of people. The distinction between what is
considered legitimate or illegitimate medical knowledge and practice is then
mapped onto a local social landscape. Descriptions of informal providers as 
‘irrational’ or ‘thug-like’ by registered practitioners, for example, are articulated
within a social hierarchy. They offer a reminder that statements about knowledge
and morality are often deeply entwined with prejudices and preconceptions based
on caste, class, gender or ethnicity. As Stacy Leigh-Pigg’s work in Nepal has
shown, the field of rural health care can prove to be a potent site for the 
production and reproduction of politically salient social categories (Leigh-Pigg
1990, 1996).
Reading between the lines of studies on informal providers from the region one
can discern the social politics of boundary making that we are concerned with in
this paper. One recent study of informal providers in north Bangladesh (Ahmed
and Hossain 2007) maps biomedical knowledge and practice onto a social 
cartography. The authors define knowledge as ‘a delineated set of biomedical
concepts and procedures accompanied by formal certified guarantees of 
competence’. Their study identifies informal providers not simply by their lack of
education or training but by their specific lack of certified knowledge from 
recognised institutions. The portrait of irrational village practitioners and their 
fatalistic rural patients also marks a social hierarchy between agents of 
development and the people they target, so that lay knowledge or practice comes
to be defined by and against the rational, educated, elite cosmopolitan. As Sarah
Pinto has put it, informal practitioners are ‘those against whom the educated and
rational self is defined’ (Pinto 2004: 356). 
2.2 Fuzzy boundaries and hybrid practices
There is considerable interest in the contemporary health literature on the ‘blurred’
boundaries between public and private, formal and informal health systems
(Bloom and Standing 2008; Bloom et al. 2008). To date, the debate has been 
concerned with public health professionals who cross over into the marketplace;
11 
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discussions have centred on government health professionals who supplement or
subsidise their low pay by selling goods and services in the medical marketplace
(Bloom and Standing 2008). The ‘porous boundary’ between the formal and 
informal sector, however, allows for movement in both directions and we broaden
this debate to consider how informal medical entrepreneurs use their associations
with ‘legitimating institutions’ in order to build reputations, gain status, and pursue
their livelihoods. Just as formal providers constantly assert and defend the 
legitimacy of their knowledge and practice in reference to those who operate 
illegitimately (see above), informal providers constantly draw upon the signs, 
symbols, and language of formal actors and institutions to legitimise themselves.
Development interventions in the arena of public health have served to 
incorporate informal providers into formal, institutionalised structures. Rural 
development projects and village health campaigns frequently recruit self 
appointed local medical practitioners as participants. Participation in NGO/state
training programmes can sanction or legitimise informal providers. Training 
programmes can offer formerly illegitimate practitioners new livelihood 
opportunities as assistant nurses, village or community health workers.
Alternatively, they can also offer new sources of institutionalised identity and 
language with which informal providers can assert themselves as experts in the
medical marketplace. Biomedical research programmes can offer a similar source
of institutional legitimacy. People who are employed to oversee and administer
clinical trials can draw on this connection when the trial is complete in order to
invest themselves with an institutional authority.
In Africa and Asia people engage with medical practitioners who are not doctors
but who ‘invent roles for themselves as medical experts and representatives of
development’ (Pinto 2004: 337). In the gaps left by legitimate public health 
systems, self-made or entrepreneurial practitioners draw upon the authority of
medical and development institutions without any formal sanction to offer services
in a medical frame. Their claims to expertise and authority invoke outside 
institutions (NGOs, local government), mobilise associations by kinship or 
marriage, deploy biomedical technologies or commodities, and communicate in
ways that present themselves as beacons of education or ‘rationality’. For 
unqualified and self-appointed rural medical practitioners in Uttar Pradesh, for
example, the use of needles provides entry into a legitimating structure; the 
injection is a performance that borrows from the work of doctors and the stuff of
hospitals (Pinto 2004: 353; Jeffery et al. 2007). In India and Southern Africa alike,
practitioners of ‘traditional’ medicine – healers and Ayurvedic doctors – draw on
biomedical symbols, treatments, instruments, and diagnostic technologies, as a
source of legitimating authority (Lambert 1996; Reynolds Whyte et al. 2003: 9;
Nisula 2006: 209). In South Africa, this is manifested also in efforts to construe
African traditional healing as ‘African Science’ (Ashforth 2005).
Current debates on informal providers within the existing literature tend not to
include in the discussion a consideration of traditions of treatment, healing and
care that exist outside a biomedical frame. Yet in Africa and Asia allopathic and
non-allopathic medicine exist side by side in the marketplace. Working definitions
of ‘informal provider’ that fail to fully address the influence and integration of 
biomedicine into other therapies, miss the everyday plurality of therapeutic 
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practice with respect to concepts, discourse, diagnostic technology, instruments
and pharmaceuticals. In South Asia, for example, there is more blurring of 
boundaries between Ayurvedic, Homeopathic and Allopathic traditions (Bode
2006; Frank and Ecks 2004; Nisula 2006) than is commonly granted and medical
systems, structures and symbolics can be said to ‘intermingle’ (Khare 1996). Rigid
definitions of biomedical practice miss the hybrid nature of everyday medical 
practice in many parts of the world where providers adapt or syncretise their 
practices and, in doing so, blur the boundaries between biomedicine and non-
allopathic traditions (Kielmann 2002; Frank and Ecks 2004; Kielmann et al. 2005;
Datye et al. 2006). 
3 Markets, medicine and the 
morality of exchange
Current debates about the activities of informal providers in markets for health
care rest on a series of apparent paradoxes and contradictions. On the one hand,
the informal economy is presented as essentially ‘unregulated’ and informal
providers are portrayed as ‘unaccountable’ economic actors prone to self-
interested behaviour. On the other hand, informal providers are frequently 
recognised as locally situated social actors who are entwined in binding 
relationships, networks of kinship, patronage and reciprocity. Similarly, on one
hand the transactions between providers and their clients are often assessed in
normative terms that imagine these as potentially therapeutic consultations. On
the other hand, these providers are frequently shown to be located in fiercely
competitive marketplaces where their everyday dispensing practices are driven by
consumer demand. 
The existing terms of debate on informal providers offer little scope for adequately
addressing the complexity of transactions that straddle the market and the social
world. For anthropologists, ‘neither world can be reduced to an externality’ (Ortiz
2005: 74). The nature of small scale, localised medical or health care business in
a highly competitive marketplace means that individual providers constantly seek
to build and maintain good relationships with their clientele by offering goods and
services that meet local expectations of care or value for money. In rural African
contexts, for example, this might mean making drugs available on credit if people
cannot pay for medication up front (see, for example, Marsh et al. 1999; Bierlich
1999). In urban South Asian settings like the slums of Karachi and Mumbai, where
poor patients can ill afford to wait and see if they have been ‘cured’ but look
instead for a temporary reprieve that can get them through the day, this might
mean that diagnostic procedures and dispensing practices with no immediately
perceptible outcome are likely to be taken as signs of ineffectiveness or corruption
(Kamat 2001: 902). 
This section examines the way in which the market and market relationships are
discussed in contemporary debates on informal providers. The interactions
between users and providers is more complex than some of the literature allows
for and we introduce a more nuanced understanding that: (a) acknowledges that
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economic activity outside the control of the state is not necessarily disorganised
or uncontrolled; (b) recognises that informal providers are concerned to make a
living but are also social actors who operate within moral economies and ethics of
care; and (c) situates informal providers in a wider pharmaceutical supply chain.
3.1 Transactional analyses and moral economies
To what extent do public health concerns with the quantity of biomedical 
knowledge or the quality of biomedical practice match the everyday expectations
and preferences that people bring to their transactions with providers? Existing
policy perspectives focus on interactions between provider and patient as a 
consultative or advice-giving moment. Researchers frequently announce that
medical sellers, vendors and pharmacists have an important role in meeting the
information demands of their clients regarding general health knowledge, drug
use and family planning (Gül et al. 2007). Yet the circumstances under which 
customers actually prompt a medicine seller for information or advice often remain
unclear. In empirical studies, information seems to remain a minor feature of
observed interactions between patent medical vendors or pharmacy attendants
and their customers. 
In many cases the transactions between medical sellers and their customers are
better understood if we think of them as market transactions rather than imagine
them through the normative lens of public health policy. Placing cost rather than
symptoms at the centre of transactions between medicine sellers and their 
customers more accurately reflects the observed content of interactions, the 
concerns of the actors, and better explains the outcomes. In research from sub-
Saharan Africa, South and South East Asia, customers are rarely reported to
actually engage vendors in anything approaching a ‘therapeutic consultation’ and
medical sellers rarely ask customers questions about their illness (Goodman et al.
2007; Chalker et al. 2000). Studies of informal providers that pay attention to the
speech economy of transactions with customers, for example, show that vendors
act primarily as salesmen who simply respond to direct requests from their clients
rather than as repositories of diagnostic wisdom or advice (Goodman et al. 2007;
Brieger et al. 2004; Kamat and Nichter 1998). Thinking about the transactions
between providers and their patients/clients as economic, means seeing them in
terms of meeting client expectations of value for money rather than high quality,
efficacy or safety.
Arguing that these transactions be understood primarily as economic is not to
suggest, however, that the actors can be understood as calculating and self-
interested individuals. Economic anthropologists do not deny that economic 
decisions may be logically reasoned or profit maximising, where choices are 
evaluated and decisions made that maximise utility. They do, however, question
the universality of this model of microeconomic behaviour (even in advanced 
capitalist societies) and recognise instead that social relations and obligations
also affect how decisions are arrived at and options evaluated.
Transactions between informal providers and their clients in the medical market-
place may not conform to the ethics of consultative practice within a biomedical
IDS WORKING PAPER 334
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paradigm but they remain embedded in value systems and ethics of care that
shape economic choices and decisions. Bottom-up approaches to biomedical
ethics recognise that informal or market based providers remain within a moral
economy of care that influences ‘the content and the nature’ of their decisions and
their communication with clients (Datye et al. 2006: 435). These value systems
configure norms of ethical practice that shape how providers perceive their role
and responsibilities to patients/clients, and what is expected or demanded of
them. A study of dispensing practices in Mumbai’s slum pharmacies, for example,
showed that vendors frequently refused to sell prescription drugs to clients who
were new or unknown to them because of concerns that they presented a ‘suicide
risk’ (Kamat and Nichter 1998). Similarly, when presented with a list of medicines
by cash-strapped clients suffering from chronic illnesses they invariably guided
them towards low cost, curative drugs over more expensive palliative medicines
(ibid.). In cases where low-income patients were observed presenting 
prescriptions for multiple medicines, pharmacy attendants frequently made 
decisions on the basis of their appropriateness and utility rather than their 
profitability. 
The social forces acting on informal providers in what are highly competitive 
medical marketplaces do create very real regulatory dynamics, even though this
dynamic might not correspond to normative assertions of what a functioning 
market for health care should look like. In East Africa, for example, where state
hospital pharmacies seldom have stocks of necessary drugs, drug shop owners
are tacitly allowed to infringe regulations designed to restrict the sale of 
prescription medications and government doctors commonly write informal
‘scripts’ for patients to take to the shops (Goodman et al. 2007). Increased 
policing of state regulations in this context would constitute a fundamental denial
of access to basic medication. Regulatory enforcers have accepted that tightening
controls on the sale and circulation of drugs would conflict with basic public health
objectives, not to mention their own understandings of the morality of the 
situation.
Interventions aimed at improving the knowledge and practice of retailers and
salespeople illustrate a preoccupation with ‘knowledge deficiencies’ and the purity
of biomedical knowledge but can ignore the practical question of whether, when,
how, or in which contexts customers actually ask the seller of medical drugs and
treatments for advice. Little surprise, perhaps, that vendor training programmes
sometimes appear to have little impact on the everyday content of transactions.
Examples from Uganda (Goodman et al. 2007) show that while interventions may
leave vendors better informed about dosages and drugs, everyday business 
pressures and economic concerns about losing customers are what determine
whether or not this information is actually used.
3.2 Livelihood strategies
Attempting to understand ‘the rationale for provider behaviour’ (Williams and
Jones 2004) rather than evaluating knowledge and practice through the normative
lens of public health policy would seem to be a precondition for coming to terms
with the factors that encourage and militate against pharmacy assistants taking on
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proactive ‘advice giving roles’. ‘Livelihood strategies’ can provide a useful way of
understanding provider behaviour, especially in highly marketised environments.
The exchange of medical commodities or services for money is a livelihood 
strategy for people with vastly different kinds of social, cultural and economic 
capital. Conceptual distinctions between formal practitioners and informal
providers suggest some kind of fundamental difference in their business practice.
Yet from a livelihoods perspective, the prescribing practices of formally regulated
doctors and the dispensing practices of unregulated medical vendors do not 
necessarily occupy different positions on a scale. Empirical studies of both groups
show that educated, certified or licensed general practitioners confront the same
pressures of competition and customer expectations as small-scale patent 
medicine vendors. Practitioners and vendors alike struggle to retain the patronage
of their clients in the face of stiff competition and must do so by meeting the
demands and expectations of customers for a particular kind of product, service
and/or treatment. 
Studies of private general practitioners in South Asia repeatedly demonstrate how
massive competition between providers drives diagnostic and prescriptive 
practices. Government doctors who moonlight as private practitioners in Karachi’s
slums, for example, recognise that they are over-medicating patients but blame
the incessant demands among patients for ‘more medicine’ and the cut throat
competition between practitioners (Thavera et al. 1998). Similarly, proliferation of
practitioners and vendors in India’s medical marketplace has created intense 
competition for patients and customers. 
Informal providers repeatedly inform researchers that the demands of their 
customers determine their sales practice but these claims are consistently 
discredited by researchers as a convenient cover for self-interest and profiteering.
On the basis of their review of literature from sub-Saharan Africa, Goodman et al.
(2007), for example, counsel against accepting statements by medicine sellers
that ‘consumer pressure’ drives their sales practices. They warn that vendors
often choose to ‘blame consumers for their own profit maximising behaviour’. One
alternative reading of these claims, for example, is not as deliberately 
disingenuous but as straightforwardly unreflexive accounts of market demand.
Just as doctors fail to recognise how the increased reporting of sickness, ill-health
and disease can be the product of prescription practices, vendors can fail to
recognise demand as an artefact of their own dispensing practices (Ecks 2008a;
Van der Geest et al. 1996). 
3.3 Pharmaceutical supply chains
As knowledge economies, health care systems are not only about the politics of
ignorance. The pharmaceutical industry is acknowledged to be ‘the main 
knowledge generator in the field’, as evidenced by the increased familiarity of
patients/clients with the names of branded pharmaceutical commodities and 
commonly prescribed allopathic medicines (Jeffery et al. 2007). Even in the
absence of information about the effects of pharmaceutical commodities, 
allopathic drugs continue to be invested with social and symbolic meanings which
lead to them being highly valued (Reynolds Whyte 1992; Reynolds Whyte and
IDS WORKING PAPER 334
16
Birungi 2000; Reynolds Whyte et al. 2003). Yet existing debates frequently 
downplay the role of pharmaceutical companies, wholesalers and marketers in
shaping everyday demand or dispensing practices (cf. Syhakhang 2002;
Syhakhang et al. 2001; T.K.C et al. 2002). The ‘logic of practice which unfolds as
different stakeholders in the medical marketplace interact and respond to each
others’ immediate and longer term needs and motivations’ (Kamat and Nichter
1998: 793) is everywhere plugged in to these global networks of information and
drugs (Petryna et al. 2006). Yet very few contemporary public health interventions
targeting the problems posed by informal providers of medicine take into account
the specific effects of capitalist marketing and strategies of supply as drug 
producers direct their products into the marketplace.
By maintaining a rigid focus on the knowledge and practice of retailers or 
salespeople, current debates about the role of informal providers in future health
systems deflect attention away from other actors in the pharmaceutical supply
chain. Relatively little is known, for example, about the ‘pharmaceutical gift cycle’
(Oldani 2004: 337) exchanges between representatives and doctors, links
between salespeople and wholesalers, marketers and pharmaceutical companies.
Yet in a medical marketplace increasingly defined by the commercial interests of
pharmaceutical companies, the dispensing practices of informal providers, the
‘institutional arrangements within which patent medical vendors obtain their 
supplies’, the way that credit schemes and targets manifest themselves in retail
practice, and the role of middlemen demand to be examined in greater detail
(Appelbaum 2005: 21; Kamat and Nichter 1998; Oladepo et al. 2007).
Discussion about knowledge and practice among informal providers that does not
move beyond the provider-client interface fails to see the relationships that 
connect actors, agents and institutions in a pharmaceutical supply chain, down
which goods and knowledge are transferred in the biomedical economy. Concerns
about holding informal providers accountable lift these individuals out of a whole
chain of commercial relationships that extend upwards and downwards. Informal
dispensers of allopathic medicines, for example, are linked to suppliers, 
wholesalers, and pharmaceutical companies. 
In the biomedical tradition, it is the potentially toxic, noxious and harmful effects of
pharmaceutical drugs that represents a key concern for public health (Reynolds
Whyte et al. 2003). Expert anxieties with regards to unregulated or informal
providers of allopathic medicine are rooted in this pharmacological knowledge that
understands the potential for harm in poorly dispensed or prescribed drugs
(Jeffery et al. 2007). But if biomedical experts recognise that pharmaceutical 
products are inherently unsafe, why do small-time dispensers (who are more likely
to respect the potency of drugs) rather than pharmaceutical giants carry the 
burden of responsibility for safety? A shift in focus away from the consumption of
drugs and distribution of knowledge, to the production of allopathic commodities
and knowledge about drugs would present new opportunities for critical 
engagement with the institutions and interests that shape markets for health care.
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4 Conclusion: studying up
Our response to the public health challenges posed by informal providers has not
been to offer a definitive set of conceptual frameworks, theories, or methodologies
from medical anthropology that have been or could be applied to the study of 
markets involving informal providers. Rather we have used this paper to ask a
series of questions about the production of knowledge, and about who informal
providers are and what they do. 
The first half of this paper was an exercise in deconstruction that asked: What do
current debates about informal providers do? On what basis is expertise or quality
of care evaluated, and do classificatory schemas antagonise social distinctions
based on class or caste? Do rigidly biomedical definitions of who an informal
provider is limit the capacity of interventions by disqualifying practitioners who
could make positive public health contributions? 
The second half of the paper presented a more complex portrait of markets that
began to ask: Do normative assumptions about what provider-client relations
should involve misconstrue the content, the interests and the ethics of existing
transactions? And, do the assumptions that underpin existing interventions result
in ineffective or limited outcomes?
This paper recognises the immediate and pressing concerns to public health 
presented by informal health care providers on the frontlines of the medical 
marketplace. But existing debates around informal providers are, almost without
exception, focused on low-level providers of health care products in ways that
neglect their relationships to the higher levels of the pharmaceutical supply chain.
Understanding what creates the demand or need for medicine requires attention
to a bigger picture beyond the small-time economic actor. Patients are situated in
medical marketplaces where ideas about health, well-being and disease are not
static but are being constantly ‘re-ordered as biomedicine becomes an 
increasingly significant reference point and a primary therapeutic resource’
(Kielmann 2002: 153). Patient perspectives and expectations shape the everyday
practices of health providers and, as ‘practitioners cater to patient perceptions of
their perceived morbidity’ (ibid.: 148), they find themselves offering as many 
services or as many drugs as possible. Indeed we would argue that public health
interventions cannot be planned without considering or engaging with the global
pharmaceutical supply chain. As it stands, however, many development 
interventions place a substantial burden of responsibility for the delivery of health
commodities and care on actors who occupy marginal or peripheral positions of
economic, political and social power; people who in relative terms remain quite
poorly placed to look after themselves.
IDS WORKING PAPER 334
18
References
Ahmed, S. and Hossain, M. (2007) ‘Knowledge and Practice of Qnqualified and
Semi Qualified Allopathic Providers in Rural Bangladesh: Implications for the HRH
Problem’, Health Policy 84: 332–43
Appelbaum, K. (2005) ‘The Anthropology of Markets’, in James Carrier (ed.), A
Handbook of Economic Anthropology, London: Edward Elgar Publishing
Ashforth, A. (2005) ‘Muthi, Medicine and Witchcraft: Regulating “African Science“
in Post-Apartheid South Africa?’, Social Dynamics 31: 211–42
Baer, Hans A; Singer, Merrill and Johnsen, John H. (1986) ‘Towards a Critical
Medical Anthropology’, Social Science and Medicine 23.2: 95–8 
Berman, P.A. (1998) ‘Rethinking Health Care Systems: Private Health Care
Provision in India’, World Development 26.8: 1463–79
Bierlich, B. (1999) ‘Sacrifice, Plants, and Western Pharmaceuticals: Money and
Health Care in Northern Ghana’, Medical Anthropology Quarterly 13: 316–37
Bloom, G. and Standing, H. (2008) ‘Future Health Systems: Why Future? Why
Now?’, Special Issue, Social Science and Medicine 66.10: 2067–75
—— (2001) Pluralism and Marketisation in the Health Sector: Meeting Needs in
Contexts of Social Change in Low and Middle-Income Countries, IDS Working
Paper 136, Brighton: IDS
Bloom, G.; Standing H. and Lloyd, R. (2008) ‘Markets, Information Asymmetry and
Health Care: Towards New Social Contracts’, Special Issue, Social Science and
Medicine 66.10: 2076–87
Bode, M. (2006) ‘Taking Traditional Knowledge to the Market: The
Commoditisation of Indian Medicine’, Anthropology and Medicine 13: 225–36
Brieger, W.R.; Osamor, P.E.; Salami, K.S.; Oladepo, O. and Otusanya, S.A. (2004)
‘Observations of Patent Medicine Vendor and Customer Interactions in Urban and
Rural Areas of Oyo State, Nigeria’, Health Policy and Planning 19: 177–82
Brugha, R. (2003) ‘Antiretroviral Treatment in Developing Countries: The Peril of
Neglecting Private Providers’, British Medical Journal 326: 1382–4
Chalker, J.; Chuc, N.T.K.; Falkenberg, T.; Do, N.T. and Tomson, G. (2000) ‘STD
Management by Private Pharmacies in Hanoi: Practice and Knowledge of Drug
Sellers’, Sexually Transmitted Infections 76: 299–302
Conteh, L. and Hanson, K. (2003) ‘Methods for Studying Private Sector Supply of
Public Health Products in Developing Countries: A Conceptual Framework and
Review’, Social Science & Medicine 57: 1147–61
Datye, V.; Kielmann, K.; Sheikh, K.; Deshmukh, D.; Deshpande, S.; Porter, J. and
Rangan, S. (2006) ‘Private Practitioners‘ Communications with Patients Around
HIV Testing in Pune, India’, Health Policy and Planning 21: 343–52
IDS WORKING PAPER 334
19
Ecks, S. (2008a) ‘Three Propositions for an Evidence Based Medical
Anthropology’, Journal of the Royal Anthropological Institute: S77–S92
—— (2008b) ‘Global Pharmaceutical Markets and Corporate Citizenship: The
Case of Novartis‘ Anti-cancer Drug Glivec’, BioSocieties 3: 165–81
El Katsha, S.; Labeeb, S.; Watts, S. and Younis, A. (2006) ‘Informal Health
Providers and the Transmission of Hepatitis C Virus: Pilot Study in Two Egyptian
Villages’, Eastern Mediterranean Health Journal 12.6: 758–67
Floyd, K.; Arora, V.K.; Murthy, K.J.R.; Lönnroth, K.; Singla, N.; Akbar, Y.; Zignol, M.
and Uplekar, M. (2006) ‘Cost and Effectiveness of the PPM-DOTS for
Tuberculosis Control: Evidence from India’, Bulletin of the World Health
Organization 84
Frank, R. and Ecks, S. (2004) ‘Towards an Ethnography of Indian Homeopathy’,
Anthropology and Medicine 11
George, A. (2007) ‘Persistence of High Maternal Mortality in Koppal District,
Karnataka, India: Observed Service Delivery Constraints’, Reproductive Health
Matters 15.30: 91–102
Gharat, M.S.; Bell, C.A.; Ambe, G.T. and Bell, J.S. (2007) ‘Engaging Community
Pharmacists as Partners in Tuberculosis Control: A Case Study From Mumbai,
India’, Research in Social and Administrative Pharmacy 3: 464–70
Goodman, C.; Kachur, P.S.; Abdulla, S.; Bloland, P. and Mills, A. (2007) ‘Drug
Shop Regulation and Malaria Treatment in Tanzania – Why do Shops Break the
Rules and Does it Matter?’, Health Policy and Planning 22: 393–403
Goodman, C.; Brieger, W.; Unwin, A.; Mills, A.; Meek, S. and Greer, G. (2007)
‘Medicine Sellers and Malaria Treatment in Sub-Saharan Africa: What do They do
and How Can Their Practice be Improved?’, American Journal of Tropical
Medicine and Hygiene 77: 203–18
Gül, H.; Omurtag, G.; Clark, P.M.; Ayfer, Tozan and Özel, S. (2007)
‘Nonprescription Medication Purchases and the Role of Pharmacists as
Healthcare Workers in Self-medication in Istanbul’, Medical Science Monitor 13:
9–14
Hall, S. (ed.) (1997) Representation: Cultural Representations and Signifying
Practices, London: Sage 
International Centre for Diarrhoeal Disease Research, Bangladesh [ICDDR]
Centre for Systematic Review (2007) What is the Non-state Sector?,  www.icd-
drb.org/activity/index.jsp?activityObjectID=3855 (accessed 14 June 2009)
Jeffery, R.; Ecks, S. and Brhlikova, P. (2007) ‘Prescribing Regulation: Rethinking
the TRIPS and GMP Regimes’, Biblio: 30.3: 45–52
Jeffery, P.; Das, A.; Dasgupta, J. and Jeffery, R. (2007) ‘Unmonitored Intrapartum
Oxytocin Use in Home Deliveries: Evidence from Uttar Pradesh, India’,
Reproductive Health Matters 15.30: 172–8
IDS WORKING PAPER 334
20
Kamat, V. (2001) ‘Private Practitioners and the Role in the Resurgence of Malaria
in Mumbai (Bombay) and Navi Mumbai (New Bombay), India: Serving the Affected
or a New Epidemic?’, Social Science and Medicine 52: 885–909
Kamat, V.R. and Nichter, M. (1998) ‘Pharmacies, Self-medication and
Pharmaceutical Marketing in Bombay, India’, Social Science and Medicine 47:
779–94
Khare, R.S. (1996) ‘Dava, Daktar, and Dua: Anthropology of Practiced Medicine in
India’, Social Science and Medicine 43: 837–48
Kielmann, K. (2002) ‘Theorizing Health in the Context of Transition: The Dynamics
of Perceived Morbidity Among Women in Peri-Urban Maharashtra, India’, Medical
Anthropology 21: 157–205
Kielmann, K.; Deshmukh, D.; Deshpande, S.; Vinita Datye; Porter, J. and 
Rangan, S. (2005) ‘Managing Uncertainty Around HIV/AIDS in an Urban Setting:
Private Medical Providers and their Patients in Pune, India’, Social Science and
Medicine 61: 1540–50 
Killewo, J.; Anwar, I.; Bashir, I.; Yunus, M. and Chakraborty, J. (2006) ‘Perceived
Delay in Healthcare-seeking for Episodes of Serious Illness and Its Implications
for Safe Motherhood Interventions in Rural Bangladesh’, Journal of Health,
Population and Nutrition 24.4: 403–12
Lambert, H. (1996) ‘Popular Therapeutics and Medical Preferences in Rural North
India’, The Lancet 348: 1706–09
Leigh-Pigg, S. (1996) ‘The Credible and the Credulous: The Question of
“Villagers’ Beliefs“ in Nepal’, Cultural Anthropology 11.2: 160–201
—— (1990) ‘Inventing Social Categories Through Place: Social Representations
and Development in Nepal’, Comparative Studies in Society and History 34:
491–513
Leonard, K.L. (2002) ‘When Both States and Markets Fail: Asymmetric Information
and the Role of NGOs in African Health Care’, International Review of Law and
Economics 22: 61–80
Lock, M. and Scheper-Hughes, N. (1996) ‘A Critical Interpretive Approach in
Medical Anthropology: Rituals and Routines of Discipline and Dissent’, in 
C.F. Sargent and T.M. Johnson (eds), Handbook of Medical Anthropology:
Contemporary Theory and Method, Westport, Connecticut: Greenwood Press
Marsh, V.M.; Mutemi, W.M.; Muturi, J.; Haaland A.; Watkins WM; Otieno G. and
Marsh K. (1999) ‘Changing Home Treatment of Childhood Fevers by Training
Shop Keepers in Rural Kenya’, Tropical Medicine and International Health 4:
383–9
Martin, E. (1994) Flexible Bodies: Tracking Immunity in American Culture from the
Days of Polio to the Age of AIDS, Boston: Beacon Press
Mills, A.; Brugha, R.; Hanson, K. and McPake, B. (2002) ‘What Can be Done
About the Private Health Sector in Low-income Countries?’, Bulletin of the World
Health Organization 80: 325–30
IDS WORKING PAPER 334
21
Nisula, T. (2006) ‘In the Presence of Biomedicine: Ayurveda, Medical Integration
and Health Seeking in Mysore, South India’, Anthropology and Medicine 13:
207–24
Okeke, T.A.; Uzochukwu, B.S.C. and Okafor, H.U. (2006) ‘An In-depth Study of
Patent Medicine Sellers’ Perspectives on Malaria in a Rural Nigerian Community’,
Malaria Journal 5
Oladepo, O.; Salami, K.K.; Adeoye, B.W.; Oshiname, F.; Ofi, B.; Oladepo, M.;
Ogunbemi, O.; Lawal, A.; Brieger, W.R.; Bloom, G. and Peters, D.H. (2007)
Malaria Treatment and Policy in Three Regions in Nigeria: The Role of Patent
Medical Vendors, Brighton: IDS
Oldani, M.J. (2004) ‘Thick Prescriptions: Towards an Interpretation of
Pharmaceutical Sales Practices’, Medical Anthropology Quarterly 18: 325–56
Ortiz, S. (2005) ‘Decisions and Choices: The Rationality of Economic Actors’, in
James Carrier (ed.), A Handbook of Economic Anthropology, London: Edward
Elgar Publishing
Petryna, A.; Lakoff, A. and Kleinman, A. (2006) Global Pharmaceuticals. Ethics,
Markets, Practices, London: Duke University Press
Pinto, S. (2004) ‘Development Without Institutions: Ersatz Medicine and the
Politics of Everyday Life in Rural North India’, Cultural Anthropology 19: 337–64
Reynolds Whyte, S. (1992) ‘Pharmaceuticals as Folk Medicine: Transformations in
the Social Relations of Health Care in Uganda’, Culture, Medicine and Psychiatry
16: 163–86
Reynolds Whyte, S. and Birungi, H. (2000) ‘The Business of Medicines and the
Politics of Knowledge in Uganda’, in L.M. Whiteford and L. Manderson (eds),
Global Health Policy, Local Realities: The Fallacy of the Level Playing Field,
London: Lynne Rienner Publishers
Reynolds Whyte, S.; Van Der Geest, S. and Hardon, A. (2003) The Social Lives of
Medicines, Cambridge: Cambridge University Press
Salim, M.A.H.; Uplekar, M.; Declercq, E.; Aung, M.; Daru, P. and Lönnroth, K.
(2006) ‘Turning Liabilities into Resources: The Informal Village Doctors and TB
Control in Bangladesh’, Bulletin of WHO 84: 479–84
Standing, H.; Mushtaque, A. and Chowdhury, R (2008) ‘Producing Effective
Knowledge Agents in a Pluralistic Environment: What Future for Community
Health Workers’, Social Science and Medicine 66.10: 2096–107
Syhakhang, L. (2002) ‘The Quality of Private Pharmacy Services in a Province of
Lao PDR: Perceptions, Practices and Regulatory Enforcements’, dissertation,
Karolinska Institutet, Stockholm, Sweden
Syhakhang, L.; Stenson, B.; Whalstrom, R. and Tomson. G. (2001) ‘The Quality of
Public and Private Pharmacy Practices: A Cross Sectional Study in the
Savannakhet Province, Lao PDR’, European Journal of Clinical Pharmacology 57:
221–7
IDS WORKING PAPER 334
22
Thavera, I.H.; Harphamb, T.; McPakec, B. and Garner. P. (1998) ‘Private
Practitioners in the Slums of Karachi: What Quality of Care do they Offer?’, Social
Science and Medicine 46: 1441–9
T.K.C., N.; Larsson, M.; Do, N.T.; Diwan, V.K.; Tomson, G.B. and Falkenberg, T.
(2002) ‘Improving Private Pharmacy Practice: A Multi-intervention Experiment in
Hanoi, Vietnam’, Journal of Clinical Epidemiology 55: 1148–55
Travis, P. and Cassels, A. (2006) ‘Safe in their Hands: Engaging Private Providers
in the Quest for Public Health Goals’, Bulletin of the World Health Organization
84: 427–8
Van der Geest, S.; Reynolds Whyte, S. and Hardon, A. (1996) ‘The Anthropology
of Pharmaceuticals: A Biographical Approach’, Annual Review of Anthropology 25:
153–78
WHO (2001) WHO Global Strategy for Containment of Antimicrobial Resistance,
Geneva: World Health Organization
WHO and USAID (2007) Public Policy and Franchising Reproductive Health:
Current Evidence and Future Directions, Guidance from a Technical Consultation
Meeting, Geneva
Williams, H.A. and Jones, C.O.H. (2004) ‘A Critical Review of Behavioral Issues
Related to Malaria Control in Sub-Saharan Africa: What Contributions have Social
Scientists Made?’, Social Science and Medicine 59: 501–23
Young, A. (1995) The Harmony of Illusions: Inventing Post-traumatic Stress
Disorder, Princeton: Princeton University Press
IDS WORKING PAPER 334
23
